![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Brazil Streamlines Approval Process for Class II Devices
Brazil Streamlines Approval Process for Class II Devices
![Brazil map](https://www.fdanews.com/ext/resources/test/Device_Images6/Brazil_Map.gif?t=1614269206&width=430)
September 28, 2020
Brazil’s National Surveillance Agency (ANVISA) is eliminating its Cadastro premarket approval pathway for Class II medical devices and in vitro diagnostics (IVDs) and is replacing it with a notification pathway that would no longer require premarket reviews.
ANVISA has also announced plans to replace the Cadastro registration requirements for Class I medical devices and IVDs with a notification-only registration system. The announcement means that both Class I and Class II devices and IVDs will be allowed to be marketed via the notification pathway.
The agency aims to free up its resources to focus on higher-risk devices and to be in alignment with recommendations from the International Medical Device Regulators Forum.
Upcoming Events
-
21Oct